Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 98

Daily deal net: September 11, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 11, 2019

Q-Ctrl controls for $15m investment

University of Sydney's quantum error-correction spinout Q-Ctrl has added $15m from investors including Main Sequence Ventures and plans to double its headcount and open a US office.

Sep 11, 2019

Trucode extricates $34m

Trucode is advancing in vivo gene editing applications for disorders including sickle cell disease that grew from Yale research and has been backed by GV and Kleiner Perkins.

Sep 11, 2019

Daily deal net: September 10, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 10, 2019

Yasa fires up $22m

University of Oxford's electric motor spinout Yasa has added $22m from investors including OSI and Parkwalk Advisors to its coffers to help it cope with growing customer demand.

Sep 10, 2019

Corporate venturing deal net: 2-6 September 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Sep 6, 2019

Cartica AI clinches series B funding

Cartica AI, an autonomous perception tech developer forged from Technion spinout Cortica, secured capital from OurCrowd, Continental, Toyota and BMW in what appears to be its first publicly-disclosed round.

Sep 5, 2019

Guiji Zhineng gets series B-plus cash

The Tencent-backed enterprise automation technology supplier has raised hundreds of millions of renminbi in a round led by CMB Telecom.

Sep 4, 2019

VIPThink invites New Oriental to series B round

The mathematics learning platform has raised a nine-figure renminbi amount in a New Oriental-led round that included Ximalaya FM.

Sep 4, 2019

Caldan calls in $2.4m

Leveraging University of Glasgow and University of Southern Denmark research, Caldan is targeting a free fatty acid receptor associated with fatty liver disease and type 2 diabetes.

Sep 4, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here